A NOVEL APPROACH FOR IN VITROSCREENING OF RECOMBINANT HUMAN CYP2D6 METABOLISM AND INHIBITION

ibuffer (pH 8.0) containing 20% glycerol (v/v), 0.5% sodium cholate (w/v), 0.1% Triton ® N-101 (w/v), 0.5 M